Clinical Trial Update: Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for HC106, an allogeneic expanded mesenchymal stem cell product derived from adipose tissue, evaluating safety in women over 50 wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence
• Urinary Incontinence

Drugs mentioned

• HC106

Snippet

Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Conditions: Urinary Incontinence Stress | Phase 1 | Status: RECRUITING